Inventory of Guidelines

ISLH is committed to ensuring an up to date inventory of guidelines that support the Hematology Laboratory community. You may view our inventory of guidelines by selecting a category/topic below. Please note that the search/sort options will only include guidelines for the currently selected category/topic.

Please note: The “Other” tab contains guidelines/best practice papers that may include both management and laboratory recommendations

Hematopathology

Guideline Title Organization Year Action
ICSH Recommendations for Monocyte Cell Lineage Morphologic Identification, Nomenclature Harmonization, and Utilization as a Biomarker ICSH 2025 View
Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach BMPG 2025 View
Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach BMPG 2023 View
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer CCMG and Canadian Association of Pathologists 2022 View
Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies CAP 2021 View

Coagulation

Guideline Title Organization Year Action
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism ASH ISTH 2026 View
Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia McMaster 2026 View
Management of Direct Oral Anticoagulants in Adult Patients Undergoing Cardiac Surgery: A Joint Consensus Statement by the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons SCA/STS 2026 View
Consensus on Aggregometry for platelet function testing in thrombocytopenic patients: Communication from the SSC of the ISTH ISTH 2026 View
Elective Surgery Guideline : Low Molecular Weight Heparin, Warfarin, Direct Oral Anticoagulant and Anti-Platelet Management NHS 2026 View
2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura ISTH 2025 View
Venous thromboembolism laboratory testing (factor V Leiden and factor II c.∗97G>A), 2025 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG) ACMG 2025 View
Stability of hemostatic parameters in whole blood, fresh plasma, and frozen plasma: literature review and recommendations from the French Society of Thrombosis and Hemostasis (SFTH) SFTH 2025 View
Facts and Misfacts on D-Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET) Italian Society on Thrombosis and Hemostasis (SISET) 2025 View
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies ISTH 2025 View
ADLM Guidance Document on Coagulation Testing in Patients Using Direct Oral Anticoagulants ADLM 2025 View
The use of DOACs in the secondary prevention of venous thromboembolism in patients with severe thrombophilia: communication from the ISTH SSC Subcommittee on Physiological Anticoagulants and Thrombophilia ISTH SSC 2024 View
International Council for Standardization in Haematology (ICSH) recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests ICSH 2024 View
Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology UK Haemophilia Centre Doctors’ Organisation / BSH 2024 View
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper 2024 View
An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies ISTH SSC 2024 View
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the BAT-LAB substudy): communication from the Platelet Physiology ISTH-SSC ISTH SSC 2023 View
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls ICSH 2023 View
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors ICSH 2023 View
Multi-center evaluation of light transmission platelet aggregation reagents: Communication from the ISTH SSC Subcommittee on Platelet Physiology ISTH 2023 View
Consensus Report on Markers to Distinguish Procoagulant Platelets from Apoptotic Platelets: Communication from the SSC of the ISTH ISTH SSC 2023 View
Assays to quantify fibrinolysis: strengths and limitations. Communication from the ISTH SSC Subcommittee on Fibrinolysis ISTH SSC 2023 View
Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and ISTH SSC 2022 View
Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee ISTH SSC 2022 View
Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies ISTH SSC 2022 View
Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline United Kingdom Haemophilia Centre Doctors’ Organisation 2022 View
Heparin Resistance — Clinical Perspectives and Management Strategies 2021 View
Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH ISTH SSC 2021 View
2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulant ICSH 2021 View
Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis ISTH SSC 2020 View
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis ISTH SSC 2020 View
Update of the guidelines for lupus anticoagulant detection and interpretation ISTH SSC 2020 View
Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH ISTH SSC 2020 View
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH ISTH SSC 2019 View
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants ICSH 2018 View
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH ISTH SSC 2018 View
European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative NIH 2017 View
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations NIH 2017 View
Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL Blood Transfusion 2017 View
Internal quality control practices in coagulation laboratories: recommendations based on a patterns-of-practice survey IQMH 2015 View
Diagnosis of inherited platelet function disorders: Guidance from the SSC of the ISTH ISTH 2015 View
Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH ISTH 2014 View
Validation of hemostasis and coagulation assays: recommendations and guidelines Independent authors (STH) 2014 View
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology UKHCDO / BCSH 2014 View

Hemoglobinopathies and Red Cell Disorders

Guideline Title Organization Year Action
Position Paper on the Management of Sickle Cell Disease in Saudi Arabia: Understanding Disease Landscape, Identifying Challenges, and Exploring Opportunities in Transfusion Therapies 2025 View
Guideline for the management of conception and pregnancy in thalassaemia syndromes: A British Society for Haematology Guideline BSH 2024 View
Guidelines for the Management of α-Thalassaemia (2023) Thalassaemia International Federation 2024 View
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission Lancet Haematology Commission 2023 View
Evidence to Improve Care: Sickle Cell Disease – Care for People of All Ages Health Quality Ontario 2023 View
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support ASH 2020 View
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain ASH 2020 View
ICSH recommendations for assessing automated high-performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2 ICSH 2015 View
ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders ICSH 2015 View
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes ICSH 2011 View
ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes ICSH 2011 View

Flow Cytometry

Guideline Title Organization Year Action
Venous thromboembolism laboratory testing (factor V Leiden and factor II c.∗97G>A), 2025 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG) ACMG Technical Standard 2025 View
Validation of a candidate international harmonisation protocol-compliant measurement procedure for reticulocyte counting using an erythrocyte gating strategy excluding the platelet component JSLH 2025 View
Highest-order reference measurement procedure compliant with international protocol for the concentration of erythrocytes and leukocytes provided by provided by International Council for Standardization in Haematology JSLH 2025 View
Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper BSH 2024 View
Diagnosis and initial treatment of transplant-eligible high-risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper BSH and UK Myeloma Society 2024 View
Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper BSH 2024 View
Standard Operation Procedure (SOP) for 5-Part Leukocyte Differential Count Using Flow Cytometry (JSLH-Diff) JSLH 2023 View
Consensus report on flow cytometry for platelet function testing in thrombocytopenic patients: communication from the SSC of the ISTH ISTH SSC 2023 View
Reference intervals of white blood cell parameters for healthy adults in Japan JSLH 2021 View
Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan JSLH 2021 View
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology ISTH SSC 2021 View
Present status and perspective of laboratory hematology in Japan: On the standardization of blood cell morphology including myelodysplasia: On behalf of the Japanese Society for Laboratory Hematology JSLH 2018 View
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders ICCS/ESCCA 2018 View
Japanese Society for Laboratory Hematology flow cytometric reference method of determining the differential leukocyte count: external quality assurance using fresh blood samples JSLH 2016 View
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. WHO 2016 View
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology CAP 2016 View
Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group PBC 2016 View
ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features ICSH 2015 View
ICSH guidelines for the standardization of bone marrow immunohistochemistry ICSH 2015 View
ICSH guidelines for the evaluation of blood cell analyzers including those used for differential leucocyte and reticulocyte counting ICSH 2014 View
ICSH guidelines for the verification and performance of automated cell counters for body fluids ICSH 2014 View
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10 ESCCA 2011 View

COVID

Guideline Title Organization Year Action
ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary ASH 2024 View
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19 ISTH 2024 View
A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH ISTH SSC 2022 View
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH ISTH SSC 2022 View
Antithrombotic agents in patients with COVID-19 CMAJ 2022 View
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S 2022 View
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 Ontario Science Table 2022 View
Alert to Health Care Professionals about a potential drug-drug interaction between Paxlovid and anticoagulants Thrombosis Canada 2022 View
WHO recommends two new drugs to treat COVID-19 WHO 2022 View
The COVID-19 Treatment Guidelines Panel's Statement on Anticoagulation in Hospitalized Patients With COVID-19 NIH 2022 View
COVID-Inflicted Coagulopathy: Expert Consensus on Management with Novel Oral Anticoagulants in India 2021 View
Evidence-Based Recommendations on the Use of Anti-SARS-CoV-2 Monoclonal Antibodies (Casirivimab + Imdevimab, and Sotrovimab) for Adults in Ontario Ontario Science Table 2021 View
Vaccine-induced immune thrombotic thrombocytopenia (VITT) - update on diagnosis and management considering different resources 2021 View
VITT, COVID-19 and the Expert Haematology Panel: The story of how the UK responded to emerging cases of vaccine-induced immune thrombocytopenia and thrombosis during the vaccination programme UK Expert Haematology Panel 2021 View
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 ADD 2021 View
Evidence-Based Use of Therapeutics for Ambulatory Patients with COVID-19 Ontario Science Table 2021 View
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 Ontario Science Table 2021 View
COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis (VITT) NICE 2021 View
Guidance for clinical case management of thrombosis with thrombocytopenia syndrome(TTS) following vaccination to prevent coronavirus disease (COVID-19) WHO 2021 View
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets EMA 2021 View
The ISTH Releases Interim Guidance on Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) ISTH 2021 View
Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology ISTH SSC 2021 View
Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology ISTH SSC 2021 View
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Interim Guidance for Healthcare Professionals in the Outpatient Setting COVID-19 Advisory for Ontario 2021 View
Recognizing, managing and reporting vaccineinduced immune thrombotic thrombocytopenia 2021 View
Intensive Care guidance for the management of vaccine induced immune-thrombocytopenia and thrombosis (VITT) UK Intensive Care Society and NACCS 2021 View
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing Infectious Diseases Society of America 2021 View
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19 ASH 2021 View
The ADAMTS13-von Willebrand factor axis in COVID-19 patients 2021 View
A living WHO guideline on drugs to prevent covid-19 WHO 2021 View
Thrombosis Canada Statement on Astrazeneca COVID-19 Vaccine and Thrombosis Thrombosis Canada 2021 View
ISTH Statement on Astrazeneca COVID-19 Vaccine and Thrombosis ISTH 2021 View
THROMBOSIS CANADA UPDATED STATEMENT ON ASTRAZENECA VACCINE AND BLOOD CLOTS - Thrombosis Canada seeks to reassure the public regarding blood clot risk and COVID-19 vaccines Thrombosis Canada 2021 View
Remdesivir for severe covid-19: a clinical practice guideline BMJ Rapid Recommendation 2020 View
IFCC Information Guide on COVID-19 IFCC 2020 View
Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic: Interim Clinical Guidance from the Anticoagulant Forum Anticoagulant Forum 2020 View
ISTH interim guidance on recognition and management of coagulopathy in COVID ISTH 2020 View
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment ISTH 2020 View
ISTH interim guidance to recognition and management of coagulopathy in COVID-19 ISTH 2020 View
Laboratory haemostasis monitoring in COVID-19 ISTH 2020 View
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19 Chinese Society on Thrombosis and Hemostasis 2020 View
Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic Reviewed by UK ITP Forum 2020 View
Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19 ISTH SSC 2020 View
Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report CHEST 2020 View
The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis ISTH SSC 2020 View
COVID-19 and its implications for thrombosis and anticoagulation ASH 2020 View
A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19 ISTH 2020 View
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays 2020 View
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline 2020 View
Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19 Related Illness ISTH SSC 2020 View
Management of the thrombotic risk associated with COVID-19: Guidance for the hemostasis laboratory 2020 View
ISTH DIC subcommittee communication on anticoagulation in COVID-19 ISTH SSC 2020 View
Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19 2020 View
Venous Thromboembolism in COVID-19 2020 View
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality 2020 View
The hematology laboratory’s response to the COVID-19 pandemic: A scoping review 2020 View
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis 2020 View
Routine laboratory testing to determine if a patient has COVID-19 Cochrane COVID-19 Diagnostic Test Accuracy Group 2020 View

Other

Guideline Title Organization Year Action
Essential laboratory tests in emergencies; on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Committee on Preparation of Laboratories for Emergencies (C-PLE) EFLM 2026 View
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients ASH 2025 View
International Committee for Standardization in Hematology (ICSH) Guidance on the Validation of Laboratory Developed Tests in Haemostasis ICSH 2025 View
Urgent Reversal of Direct Oral Anticoagulants in Critical and Life-Threatening Bleeding: A Multidisciplinary Expert Consensus 2024 View
Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society GIHP 2024 View
Guidelines for the Use of Laboratory Tests for Iron Deficiency (CLP 002) Ontario Association of Medical Laboratories (OAML) 2024 View
Guidelines & Recommendations: Whole Blood, Leukocytes Reduced Recommendations National Advisory Committee on Blood and Blood Products 2024 View
Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH ISTH SSC 2024 View
Management of Bleeding and Thrombotic Complications During Pediatric Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference PEACE 2024 View
Recommendations on Monitoring and Replacement of Antithrombin, Fibrinogen, and Von Willebrand Factor in Pediatric Patients on Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation Collaborative Consensus Co PEACE 2024 View
Prospective, International, Multisite Comparison of Platelet Isolation Techniques for Genome-Wide Transcriptomics: Communication form the SSC of the ISTH ISTH SSC 2024 View
Reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH: R1 ISTH SSC 2024 View
Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: Communication from the ISTH SSC on Perioperative and Critical Care Thrombosis and Hemostasis ISTH SSC 2024 View
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation Chinese Society of Cardiology / Chinese Medical Association / Heart Rhythm Committee of Chinese Soci 2024 View
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Hemophilia A and B based on the GRADE methodology ISTH 2024 View
Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline BSH 2024 View
Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding ESAIC 2024 View
A British Society for Haematology guideline on the assessment and management of bleeding risk prior to invasive procedures BSH 2024 View
International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy The Korean Society of Gastrointestinal Endoscopy Task Force on Clinical Practice Guidelines 2024 View
Standardisation of Definition and Management for Bleeding Disorder of Unknown Cause: Communication from the SSC of the ISTH ISTH SSC 2024 View
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence International Union of Angiology 2024 View
UK Transfusion Laboratory Collaborative: Minimum standards for staff qualifications, training, competency and the use of information technology in hospital transfusion laboratories 2023 UK Transfusion Laboratory Collaborative 2024 View
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline BSH 2024 View
Management of pregnancy and delivery in congenital fibrinogen disorders: Communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen ISTH SSC 2024 View
The management of newly diagnosed large B-cell lymphoma: A British Society for Haematology Guideline BSH 2024 View
Multidisciplinary Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians 2024 View
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (fifth edition) American Society of Regional Anesthesia and Pain Medicine 2024 View
Multidisciplinary Expert Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians 2024 View
Management of chemotherapy-induced thrombocytopenia: guidance from the ISTH Subcommittee on Hemostasis and Malignancy ISTH SSC 2023 View
Clinical care of pediatric patients with or at risk of postthrombotic syndrome: guidance from the ISTH SSC Subcommittee on pediatric and neonatal thrombosis and hemostasis ISTH SSC 2023 View
Revised transparency rules for the EU Clinical Trials Information System (CTIS) EMA 2023 View
Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa N/A 2023 View
A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies BSH 2023 View
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria ACR / EULAR 2023 View
Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis ISTH 2023 2023 View
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology Swiss Society of Hematology 2023 View
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosi ESC and ISTH 2023 View
Emergency management of patients with Glanzmann thrombasthenia: consensus reccommendations from the French reference center for inherited platelet disorders French reference center for inherited platelet disorders 2023 View
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance EHA, ISTH, EAHAD, ESO 2023 View
Position statement from the Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and Vascular Society of India on gastrointestinal bleeding and endoscopic procedures in patients on antiplatelet and/or anticoagula Indian Society of Gastroenterology, Cardiological Society of India, Indian Academy of Neurology and 2023 View
American Society of Hematology 2023 Guidelines for Management of Venous Thromboembolism: Thrombophilia Testing ASH 2023 View
GRADE guidance 36: updates to GRADE's approach to addressing inconsistency GRADE 2023 View
Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine Saudi Critical Care Society 2023 View
British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves British Society for Haematology 2023 View
Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis ISTH SSC 2023 View
Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasis on vascular endothelium-related biomarkers in disseminated intravascular coagulation ISTH SSC 2023 View
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management 2023 View
Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care - Second update 2022 European Society of Anaesthesiology and Intensive Care 2023 View
Recommendation on the Nomenclature for Anticoagulants: Updated Communication from the ISTH SSC Subcommittee on the Control of Anticoagulation ISTH SCC 2023 View
Management of rare inherited bleeding disorders: proposals of the French Reference Centre on Haemophilia and rare coagulation disorders French Reference Centre on Haemophilia and rare coagulation disorders 2023 View
Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients 2023 View
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis ISTH SSC 2022 View
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis ISTH SSC 2022 View
Peri-procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH ISTH SSC 2022 View
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Card ESC and endorsed by ESAIC 2022 View
Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH ISTH SSC 2022 View
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline CHEST 2022 View
Perioperative Management of Direct Oral Anticoagulants in Cardiac Surgery: Practice Recommendations Based on Current Evidence 2022 View
Consensus document of the Spanish Society of Digestives Diseases and the Spanish Society of Thrombosis and Haemostasis on massive nonvariceal gastrointestinal bleeding and direct-acting oral anticoagulants Spanish Society of Digestives Diseases and Spanish Society of Thrombosis and Haemostasis 2022 View
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia 2022 View
AANMCO position paper ‘Appropriateness of prescribing direct oral anticoagulants in stroke and systemic thromboembolism prevention in adult patients with non-valvular atrial fibrillation’ ANMCO 2022 View
ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes ANMCO 2022 View
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association AHA / ASA 2022 View
Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis ISTH SSC 2022 View
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum Anticoagulant Forum 2022 View
Managing invasive procedures in haemophilia patients with limited resources, extended half-life concentrates or non-replacement therapies in 2022 2022 View
Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding AICE / SISET 2022 View
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute Cardio Vascular ESC Working Group on Thrombosis 2022 View
Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH ISTH SSC 2022 View
Bleeding disorders in implant dentistry: a narrative review and a treatment guide 2022 View
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period American College of Gastroenterology and Canadian Association of Gastroenterology 2022 View
Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document Multidisciplinary Consensus 2022 View
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopenic purpura published by the International Society on Thrombosis and Haemostasis European Renal Best Practice 2022 View
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH) German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH) 2022 View
Management of DOAC in patients undergoing planned surgery or invasive procedure: FCSA position paper FCSA 2021 View
Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH ISTH SSC 2021 View
European principles of care for women and girls with inherited bleeding disorders European Association for Haemophilia and Allied Disorders 2021 View
Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update 2021 View
Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology ISTH SSC 2021 View
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation ISTH SSC 2021 View
2021 Guidelines on the Diagnosis and Management of VWD ASH, ISTH, NHF, WFH 2021 View
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation European Heart Rhythm Association 2021 View
Comment: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 2021 View
Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH ISTH SSC 2020 View
A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia BSH 2020 View
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) ECS 2020 View
Standardizing Care to Manage Bleeding Disorders in Adolescents with Heavy Menses—A Joint Project from the ISTH Pediatric/Neonatal and Women's Health SSCs ISTH SSC 2020 View
WFH Guidelines for the Management of Hemophilia, 3rd edition WFH 2020 View
Investigation and management of erythrocytosi 2020 View
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET AICE 2020 View
ISTH Guidelines for Treatment of Thrombotic Thrombocytopenic Purpura ISTH 2020 View
International Recommendations On The Diagnosis And Treatment Of Acquired Hemophilia A 2020 View
Anticoagulant therapy for splanchnic vein thrombosis ISTH SSC 2020 View
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis ISTH SSC 2020 View
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia 2020 View
Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura ISTH 2020 View
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism ASH 2020 View
Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020 Canadian Stroke Best Practice Recommendations (CSBPR) 2020 View
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee ACC 2020 View
AGA Clinical Practice Update: Coagulation in Cirrhosis AGA 2019 View
EULAR recommendations for the management of antiphospholipid syndrome in adults EULAR 2019 View
Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Edition American Society for Apheresis 2019 View
Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH ISTH SSC 2018 View
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome McMaster RARE-Bestpractices project group 2018 View
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when European Myeloma Network 2018 View
Review of the NICE guidelines for multiple myeloma NCBI 2017 View
Acquired hemophilia A: Updated review of evidence and treatment guidance. HTRS 2017 View
Guideline for the diagnosis and management of the rare coagulation disorders.  A United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology UKHCDO / BCSH 2014 View
Patient self-testing and self-management oforal anticoagulant with vitamin K antagonists: guidance from the British Committee for Standards in Haematology BCSH 2014 View
Diagnosis and management of acquired coagulation inhibitors: a guideline form UKHCDO UKHCDO / BCSH 2013 View
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition) UKHCDO / BCSH 2013 View
WFH Guidelines for the Management of Hemophilia, 2nd edition WFH 2012 View